2010 Information Days:
London – 29 November
Edinburgh - 6 December
Manchester - 13 December
Most medicines are developed and prescribed to a one-size-fits-all model. Perhaps then it is unsurprising that most of them are only effective in 30-70% of patients. Because the technology to predict which medicines will work for which patient is at a very early stage, prescribing usually follows a trial and error approach. Recent advances in genetics and diagnostic technologies mean that in some cases it may now be possible to subgroup patients (ie, to stratify them) according to which treatments will work best for them.
As part of an £11m programme in stratified medicines, the Technology Strategy Board will invest:
• up to £5.6m in collaborative research and development projects in the field of tumour profiling and data capture
• up to £1.5m in collaborative research and development projects that aim to develop and adopt business models and value systems in this area
• furthermore the Technology Strategy Board and Medical Research Council (MRC) are to invest
• up to £4m in collaborative research and development projects developing biomarkers in the area of inflammation and immunology
This meeting is designed to set the scene for the upcoming collaborative research funding call, to supply some information about the funding call and to provide the opportunity to develop potential consortia.
The event will also include an option for delegates to take part in a number of structured 1:1 'matchmaker' or collaboration meetings. To be able to participate in the 1:1 meetings you must create a short profile of yourself and your organisations activities and collaboration wishes when you register for the event.
For more details and to book your place,
click here.
If your enquiry is about the Stratified Medicines Programme please contact:
Mr Terry O'Neill
Knowledge Transfer Manager
HealthTech and Medicines KTN
Telephone 01223 899 000
E-Mail
t.oneill@twi.co.uk For information on using the event website or the 1:1 meetings selection systems please contact:
Mr Phil Eadon
C/O The Allancia Group
Telephone: 0191 415 7340
e-mail:
phil.eadon@allancia.com